Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Health risk and health seeking behaviours among people who inject performance and image enhancing drugs who access needle syringe programs in Australia
Katinka van de Ven, Lisa Maher, Handan Wand, et al.
Drug and Alcohol Review (2018) Vol. 37, Iss. 7, pp. 837-846
Closed Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

The emergence of Exercise Addiction, Body Dysmorphic Disorder, and other image-related psychopathological correlates in fitness settings: A cross sectional study
Ornella Corazza, Pierluigi Simonato, Zsolt Demetrovics, et al.
PLoS ONE (2019) Vol. 14, Iss. 4, pp. e0213060-e0213060
Open Access | Times Cited: 101
Exploring the experiences of general practitioners working with patients who use performance and image enhancing drugs
Matthew Dunn, Timothy Piatkowski, Bianca Whiteside, et al.
Performance Enhancement & Health (2023) Vol. 11, Iss. 2, pp. 100247-100247
Closed Access | Times Cited: 35
Beyond the law: Exploring the impact of criminalising anabolic–androgenic steroid use on help-seeking and health outcomes in Australia
Timothy Piatkowski, Nick Gibbs, Matthew Dunn
Journal of Criminology (2023) Vol. 57, Iss. 1, pp. 62-82
Open Access | Times Cited: 32
Gendered perspectives on women’s anabolic–androgenic steroid (AAS) usage practices
Timothy Piatkowski, Jonathan Robertson, Séverine Lamon, et al.
Harm Reduction Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 23
Exploring the role of community pharmacies as a harm reduction environment for anabolic–androgenic steroid consumers: triangulating the perspectives of consumers and pharmacists
Timothy Piatkowski, Sarah Benn, Lkhagvadulam Ayurzana, et al.
Harm Reduction Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 14
Masculine enhancement as health or pathology: gender and optimisation discourses in health promotion materials on performance and image-enhancing drugs (PIEDs)
Gemma Nourse, Suzanne Fraser, David Moore
Health Sociology Review (2024) Vol. 33, Iss. 3, pp. 289-305
Open Access | Times Cited: 9
Understanding harm reduction perspectives of performance and image enhancing drug consumers and health care providers
Timothy Piatkowski, Leanne Hides, Katherine M. White, et al.
Performance Enhancement & Health (2022) Vol. 10, Iss. 3, pp. 100223-100223
Open Access | Times Cited: 37
Polysubstance use practices among women using anabolic-androgenic steroids (AAS)
Timothy Piatkowski, Jonathan Robertson, Matthew Dunn
Performance Enhancement & Health (2023) Vol. 11, Iss. 2, pp. 100248-100248
Closed Access | Times Cited: 20
Polydrug use and polydrug markets amongst image and performance enhancing drug users: Implications for harm reduction interventions and drug policy
Mike Salinas, William Floodgate, Robert Ralphs
International Journal of Drug Policy (2019) Vol. 67, pp. 43-51
Open Access | Times Cited: 49
Treatments for people who use anabolic androgenic steroids: a scoping review
Geoff Bates, Marie Claire Van Hout, Joseph Tay Wee Teck, et al.
Harm Reduction Journal (2019) Vol. 16, Iss. 1
Open Access | Times Cited: 44
“You Could Try This Compound, but it Might Send You nuts”: How Steroid Suppliers Perceive the Underground Market and Their ‘Hybrid’ Role within It
Timothy Piatkowski, Steve Vigorous, Luke Cox, et al.
Deviant Behavior (2024), pp. 1-12
Open Access | Times Cited: 5
Australia's Adonis: Understanding what motivates young men's lifestyle choices for enhancing their appearance
Timothy Piatkowski, Katherine M. White, Leanne Hides, et al.
Australian Psychologist (2019) Vol. 55, Iss. 2, pp. 156-168
Open Access | Times Cited: 42
Steroid Madness- has the dark side of anabolic-androgenic steroids (AAS) been over-stated?
Kyle Mulrooney, Katinka van de Ven, Jim McVeigh, et al.
Performance Enhancement & Health (2019) Vol. 6, Iss. 3-4, pp. 98-102
Open Access | Times Cited: 36
The pharmaceuticalisation of ‘healthy’ ageing: Testosterone enhancement for longevity
Matthew Dunn, Kyle Mulrooney, Cynthia Forlini, et al.
International Journal of Drug Policy (2021) Vol. 95, pp. 103159-103159
Closed Access | Times Cited: 29
Exploring the Impacts of Rurality on Service Access and Harm Among Image and Performance Enhancing Drug (IPED) Users in a Remote English Region
Luke A. Turnock, Kyle Mulrooney
Contemporary Drug Problems (2023) Vol. 50, Iss. 2, pp. 232-253
Open Access | Times Cited: 12
Community pharmacy’s role in dispensing androgens and supporting harm reduction amid current policy dilemmas
Timothy Piatkowski, Lkhagvadulam Ayurzana, Michelle A. King, et al.
Substance Abuse Treatment Prevention and Policy (2025) Vol. 20, Iss. 1
Open Access
Tracing the Impact of Media, Cultural Narratives, and Social Perceptions on Australia's Anabolic-Androgenic Steroid Communities
Timothy Piatkowski, Monica J. Barratt, Ross Coomber, et al.
Contemporary Drug Problems (2025)
Closed Access
The modes of administration of anabolic-androgenic steroid (AAS) users: are non-injecting people who use steroids overlooked?
Katinka van de Ven, Renee Zahnow, Jim McVeigh, et al.
Drugs Education Prevention and Policy (2019) Vol. 27, Iss. 2, pp. 131-135
Open Access | Times Cited: 23
Exploring the harms arising from polysubstance use among performance and image enhancing drug users among young Australian men
Timothy Piatkowski, Matthew Dunn, Katherine M. White, et al.
Performance Enhancement & Health (2021) Vol. 9, Iss. 3-4, pp. 100197-100197
Open Access | Times Cited: 20
Stigma and the Use of Anabolic Androgenic Steroids by Men in the United Kingdom
Jim McVeigh, Geoff Bates
Springer eBooks (2022), pp. 121-146
Closed Access | Times Cited: 14
Physical Activity and Exercise Addiction During the Covid-19 Pandemic in Italy
Franca Ceci, Francesco Di Carlo, Julius Burkauskas, et al.
International Journal of Mental Health and Addiction (2022) Vol. 21, Iss. 6, pp. 3678-3698
Open Access | Times Cited: 13
Polydrug use and drug market intersections within powerlifting cultures in remote South-West England
Luke A. Turnock
Performance Enhancement & Health (2021) Vol. 8, Iss. 4, pp. 100186-100186
Closed Access | Times Cited: 17
Anabolic-androgenic steroid use: Patterns of use among a national sample of Canadian adolescents and young adults
Kyle T. Ganson, Laura Hallward, Mitchell L. Cunningham, et al.
Performance Enhancement & Health (2022) Vol. 11, Iss. 1, pp. 100241-100241
Open Access | Times Cited: 11
Identifying best-practice amongst health professionals who work with people using image and performance enhancing drugs (IPEDs) through participatory action research
Katinka van de Ven, Ian D. Boardley, Martin Chandler
Qualitative Research in Sport Exercise and Health (2021) Vol. 14, Iss. 2, pp. 199-215
Closed Access | Times Cited: 14
Double trouble? A mixed methods study exploring experiences with combined use of anabolic-androgenic steroids and psychoactive substances among women
Ingrid Amalia Havnes, Marie Lindvik Jørstad, Astrid Bjørnebekk
Performance Enhancement & Health (2021) Vol. 9, Iss. 3-4, pp. 100198-100198
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top